Femme et Homme
- | Pays :
- Italy
- United States
- Austria
- Les 8 autres...
- | Organes : -
- | Spécialités : -
Extrait
This 6-month open label study will evaluate the long term safety of bosentan (via oxygen saturation) and efficacy (exercise capacity) in patients who have completed the BREATHE-5 study (PAH related to Eisenmenger physiology). Treatment duration is 6 months.
Critère d'inclusion
- pulmonary arterial hypertension